Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05535062 · ClinicalTrials.gov registry record · NA
Study to Evaluate Treatment Effects Associated With the NeuroStar SoftStart Treatment Feature
A NA study, sponsored by Neuronetics.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT05535062: Completed NA study, sponsored by Neuronetics.
NCT05535062 is a NA study that has completed, run by Neuronetics. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05535062, a NA study, has completed, sponsored by Neuronetics.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the comfort of the NeuroStar® Advanced Therapy System regular prescribed TMS protocol versus a New Feature.
Primary Outcome
The average Visual Analog Scale scores for the two conditions Dash protocol and modified DASH. VAS - Visual Analog Scale range is 0-100 (0- no pain/discomfort; 100- extreme discomfort/worse pain)
Interventions
- DEVICE repetitive Transcranial Magnetic Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-11-07 |
| Est. Completion | 2023-09-27 |
| Phase | NA |
What the finished NCT05535062 record still lists
NCT05535062 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which repetitive Transcranial Magnetic Stimulation is the first listed.
NCT05535062 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05535062 about?
NCT05535062 is a clinical study titled "Study to Evaluate Treatment Effects Associated With the NeuroStar SoftStart Treatment Feature". The purpose of this study is to evaluate the comfort of the NeuroStar® Advanced Therapy System regular prescribed TMS protocol versus a New Feature.
What is the current status of trial NCT05535062?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-11-07. Estimated completion is 2023-09-27.
What interventions are being tested in trial NCT05535062?
The interventions under investigation include: repetitive Transcranial Magnetic Stimulation (DEVICE).
Who is sponsoring clinical trial NCT05535062?
This trial is sponsored by Neuronetics, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05535062's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI